Sera Prognostics (SERA)
(Real Time Quote from BATS)
$6.95 USD
-0.04 (-0.57%)
Updated Aug 30, 2024 12:34 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
SERA 6.95 -0.04(-0.57%)
Will SERA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SERA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SERA
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates
Pediatrix Medical Group (MD) Q2 Earnings Surpass Estimates
SERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cencora (COR) Surpasses Q3 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) Q2 Earnings and Revenues Beat Estimates
Encompass Health (EHC), Piedmont Expand Ties to Serve Georgia
Other News for SERA
SERA Crosses Below Key Moving Average Level
Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
TD Cowen Sticks to Their Buy Rating for Sera Prognostics (SERA)